Blog

Caprion is hiring - Belgium biotech

Caprion Biosciences (Belgium) will double its workforce by 2019: new positions available

Following a growing demand for its immune monitoring services in Europe, the European site of Caprion Biosciences will double its workforce by the end of 2019, looking for new profiles to join the team in Gosselies, Belgium.

Lire la suite
Miracor Medical hiring via pahrtners

Miracor Medical relocates to Liège: new positions available

Following a new financing of € 25m, Miracor Medical relocates from Austria to Awans in Belgium where open positions are available.

Lire la suite
smartnodes hiring

Smart cities: public lighting revolution by Belgian tech startup SmartNodes

The ULg/UCL spin-off SmartNodes, launched in 2014, proposes a smart system revolutionizing the concept of public lighting: providing light only when and where needed, at the right level.

Lire la suite
Confo therapeutics recruiting

Innovative Belgian drug discovery biotech Confo Therapeutics is recruiting

In February 2017, the Belgian drug discovery Confo Therapeutics, a spin-off from Vrije Universiteit Brussel and VIB, announced that it received two grants bringing in a total of € 2.6 million over a period of two years.

Lire la suite
CEO Mirmex microtech

Become the CEO of promising micro-tech start-up MirMex

UCL spin-off MirMex developed a promising technology to improve the power density of high-end electric micro-motors by more than 30%*. Never heard about micro-motors? This 1B$ high-performance market supplies various sectors such as medical devices, aeronautics, robotics or industrial automation.

Lire la suite

PaHRtners announces new strategic HR collaboration with Novadip

Novadip Biosciences shows the ambition to grow to a worldwide class. The Belgian-based biotech company recently announced the closing of a €28 million Series A financing to advance breakthrough cell therapy pipeline with its lead compound Creost ®.

Lire la suite

PaHRtners - iTeos Therapeutics recrutement biotechnologies Belgique

Biotech : iTeos Therapeutics triple ses équipes en signant son accord stratégique avec Pfizer

La société de biotechnologie iTeos Therapeutics annonce une collaboration stratégique avec Pfizer sur le développement de traitements contre le cancer. Cet important soutien financier va permettre à iTeos de tripler ses effectifs en Wallonie. PaHRtners vous détaille les profils recherchés.

Lire la suite